
Lord Bethell
@JimBethell
Followers
16K
Following
12K
Media
3K
Statuses
20K
Former Health minister. Member of the House of Lords. Health Nation.
ÜT: 51.508702,-0.094157
Joined June 2009
My Mother's post-natal depression led to chaotic life of drink, drugs, divorce and ultimately, when I was nine years old, her death. I have spoken about this to the podcast "Past Imperfect" with Alice Thomson and Rachel Sylvester in The Times. 1/4 https://t.co/fZ7lcd5qDh
78
58
387
Innovation is exploding. But unless we redesign how we deliver it, we risk leaving patients behind. Let’s build a system that’s fit for the future. #HealthNation #Innovation #NHS #EnergyBills #Alzheimers 5 of 5
0
0
11
We have gone a step further with Noa: memories are machine encoded and stored privately on encrypted servers with **no rich media retained** So you can feel secure using Noa for recall years in the future.❤️ In true Brilliant Labs fashion, we built this because we believed it
2
5
25
🧬 CAR-T cancer therapy: Hospital = £30,800/year Home = £16,395/year Admin burden and legacy systems block cheaper options. 🔗 https://t.co/bvGwJ0mDSd 4 of 5
1
0
6
💉 Monoclonal antibodies: Hospital IV = £2,867/year Home injection = £1,457/year Yet NHS delivery favours the more expensive route. 🔗 https://t.co/4ECvVRpt0K 3 of 5
pharmaceutical-journal.com
Since August 2024, the National Institute for Health and Care Excellence (NICE) has published two draft guidance papers relating to new monoclonal antibody treatments for Alzheimer’s disease (AD) –...
1
0
2
🧠 NICE rejected Alzheimer’s drugs lecanemab & donanemab. Even at £0 drug cost, NHS delivery costs £19k/year per patient. 🔗 https://t.co/2z0YYWBSvH 2 of 5
nice.org.uk
The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs
1
0
2
Ok Veo 3.1 is insane. Now with more realism, more control, 1080p with synced audio. And people can't stop building full length videos in Invideo. 5 wild examples + how to: 1. AI spec ad inspired by iconic Old Spice ad
20
125
348
Even if energy were free, household bills would still rise due to government-imposed extras, according to yesterday's shocking energy boss testimony. It's the same pattern in health: breakthrough treatments blocked not by drug cost, but by regulation and NHS delivery model. 1 of
2
8
29
Conducted by the Dean of Westminster and attended by Her Majesty the Queen, it was a moment of quiet reflection to give thanks to the custodians of the land and to celebrate the rich potential of the future. 3 of 3
0
2
3
@HenryDimbleby I loved the traditional harvest loaf, with a tiny traditional mouse, produced by Morrisons, Britain's kick-ass vertically-integrated retailer that owns Blueprint Farms Ltd. 2 of 3
2
3
12
The National Harvest Festival at Westminster Abbey perfectly captured the quiet, dignified vibrance of the modern British countryside. 1 of 3
3
3
12
Junior minister Chris Ward has been sent to answer the UQ on behalf of the PM.
1
1
2
Yesterday, we were delighted to host an event in Parliament attended by over 100 MPs and Peers to launch our new report, ‘Prostate Cancer Screening: The Impact on the NHS’. We'd like to thank our co-sponsors, @CalvinBailey @DavidLammy and PCR Ambassador, @RishiSunak for their
1
2
12
If you cannot manage a safe age verification system for your workforces, you should not be running a store that sells restricted materials. It’s one of the required skills of retailers. These adverts are so bogus.
Age verification in store is already a key trigger of abuse directed at staff. The Tobacco & Vape Bill means it will only get worse. Atul Sodha is asking the government to consider us in this Bill. Make your voice heard & to sign our open letter to @PeterKyle MP today!
0
0
2
8/ The debate isn't "should healthy men be invited?"—it's "can we offer risk-adapted early detection using modern tools to those who want it?" The answer, increasingly, is yes. 6/6
0
0
1
7/ Only 50% of UK prostate cancers are caught early vs NHS 75% target. Black men face 1-in-4 lifetime risk. Waiting for perfection while men die of preventable late-stage disease isn't evidence-based—it's risk-averse paternalism. 5/6
1
0
0
6/ Prostate Cancer UK's TRANSFORM trial (£42m) is building the evidence base for a national screening programme targeting high-risk men—exactly the nuanced, modern approach the UK NSC needs to see. 4/6
1
0
0
4/ "Biopsies cause infection & impotence"—historically true with transrectal biopsies. The NHS has now adopted transperineal biopsies, virtually eliminating sepsis risk and improving detection. NICE endorsed this in 2023. 3/6
1
0
0
3/ "Overdiagnosis causes harm"—yes, in the PSA-only era. But data-led MRI-first pathways (now rolled out across the NHS) slash unnecessary biopsies while finding more clinically significant cancers. 2/6
1
0
0
Prof Baum's letter misses the point: the CAP trial he chaired tested a single PSA invite 15 years ago—not today's risk-adapted, MRI-first pathways that Cancer Research UK and Prostate Cancer UK are driving forward. A thread... https://t.co/ApVRznXQdf 1/6
1
1
1